GE

Genomictree Inc.

A molecular diagnostics company developing tests for the early detection of cancer.

228760 | KO

Overview

Corporate Details

ISIN(s):
KR7228760005
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노10로 44-6, 대전광역시

Description

Genomictree Inc. is a molecular diagnostics company that develops and commercializes products for the early detection and diagnosis of cancer. The company specializes in epigenomics, utilizing its proprietary genomic-scale discovery tools to identify DNA methylation biomarkers. Its flagship product line, EarlyTect®, offers non-invasive tests for the early screening of colorectal, lung, and bladder cancers. Additionally, Genomictree provides AccuraTect™, a companion diagnostic test for cancer. The company's mission is to improve patient quality of life and reduce medical costs through accessible and accurate early-stage cancer detection.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-12 00:00
자기주식처분결과보고서
Korean HTML 17.0 KB
2026-01-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2026-01-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2026-01-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.6 KB
2026-01-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.7 KB
2026-01-09 00:00
주요사항보고서(자기주식처분결정)
Korean HTML 30.6 KB
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.1 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.6 MB
2025-06-18 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.7 KB
2025-06-18 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.7 KB
2025-06-18 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.5 KB
2025-06-18 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.5 KB
2025-06-16 00:00
자기주식처분결과보고서
Korean HTML 16.7 KB
2025-06-11 00:00
주요사항보고서(자기주식처분결정)
Korean HTML 29.1 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 1.3 MB

Automate Your Workflow. Get a real-time feed of all Genomictree Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genomictree Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genomictree Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BioSenic SA Logo
Develops therapies for autoimmune diseases, inflammation, and bone disorders.
Belgium
BIOS
BIOTECH Logo
A biotechnology group offering preclinical services, intein development, and licensing.
Spain
BST
Biovica International B Logo
Develops blood-based biomarker assays for cancer therapy monitoring.
Sweden
BIOVIC
Bonus BioGroup Ltd. Logo
A clinical-stage biotech firm developing cell therapy and tissue engineering products.
Israel
BONS
BRAIN Biotech AG Logo
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
Germany
BNN
BriaCell Therapeutics Corp. Logo
Clinical-stage immuno-oncology company developing cellular immunotherapies for cancer.
United States of America
BCTX
BSF ENTERPRISE PLC Logo
Develops cell-based solutions for cultivated meat, leather, and corneal repair.
United Kingdom
BSFA
BullFrog AI Holdings, Inc. Logo
A technology company applying AI and machine learning to drug development.
United States of America
BFRG
Burning Rock Biotech Ltd Logo
A global diagnostics company specializing in precision oncology using NGS technology.
United States of America
BNR
Cabaletta Bio, Inc. Logo
Develops engineered T cell therapies for B cell-mediated autoimmune diseases.
United States of America
CABA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.